SeaStar Medical Holding Corporation Share Price
ICUSeaStar Medical Holding Corporation Stock Performance
Open $2.76 | Prev. Close $2.64 | Circuit Range N/A |
Day Range $2.66 - $2.76 | Year Range $0.22 - $5.04 | Volume 970 |
Average Traded $2.71 |
SeaStar Medical Holding Corporation Share Price Chart
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $2.88 | $2.83 | -1.57% |
08-Jun-26 | $3.02 | $2.87 | -1.37% |
05-Jun-26 | $3.04 | $2.91 | -7.91% |
04-Jun-26 | $3.32 | $3.16 | -3.95% |
03-Jun-26 | $3.47 | $3.29 | -6.93% |
02-Jun-26 | $3.65 | $3.54 | -3.15% |
01-Jun-26 | $3.71 | $3.65 | -1.08% |